1. The Rise of A Theranostic Empire: Good Governance and Precision Oncology.- 2. 18 FDG PET CT assessing Inmunotherapy response.- 3. Radionuclide Therapy in Brain Tumours.- 4. From Concept to Clinic and Comercialisation - Cowboys Wanted.- 5. From Radiochemistry of the Lanthanides to 225Ac and the interference with Richard Baum .- 6. How do you feel about dosimetry?" The Gretchenfrage of Radionuclide Therapy.- 7. The LuGenIum Triptych Ode to a Theranostic Transcriptome.- 8. A tree can be recognized by its fruit.- 9. IAEA Strategy for Enhancing the Sustainability of Nuclear Medicine in Low- and Middle- Income Countries.- 10. Combining surgery with peptide receptor radionuclide therapy - a step forward in treatment of advanced neuroendocrine tumours.- 11. Modern diagnostic and therapeutic approaches in thyroid diseases - Theranostics and the changing role of radioactive isotopes -.- 12. Cardiotoxicity of targeted therapies: Imaging of Heart Does Matter.- 13. Following the co-evolution of Innovation and demand in the field of precision oncology.- 14. Fighting for PET in German oncological guidelines and for its reimbursement by Statutory Health Insurances.- 15. Precision Oncology with PSMA-targeted Alpha Particle Therapy of mCRPC.- 16. From Radioimmunodetection to Radiomolecular Precision Oncology via Radionanotargeting by Intelligent Multidisciplinary Radiotheragnostic Nanoparticles.- 17. Nuclear medicine and surgery a new productive new marriage.- 18. 'PSMA Radioligand Therapy - A Revolution in the Precision Oncology of Prostate Cancer'.- 19. The Role of Individuals for Innovation: The Nuclear Medicine Biotope.- 20. Working at ISOTOPENTHERAPIESTATION D3- a daily challenge or adventure never stops.- 21. Combining targeted radiation therapies in modern clinical oncological practice.- 22. Theranostic Radiopeptides in Nuclear Oncology: Design, Preclinical Screening & Clinical Translation.- 23. Terbium "Sisters": More than just a "Swiss Army Knife".- 24. High-Performance Radiopharmacy - The Base for Precision Oncology.- 25. Analyzing the science footprint of Richard P. Baum.- 26. Ac-225 PSMA in metastatic prostate cancer without previous chemotherapy.- 27. 'Sola dosis facit venenum: Dosimetrie in Precision Oncology with Radiolabelled Probe'.- 28. theranostic pair 203Pb and 212Pb for image-guided alpha/beta particle therapy for cancer..- 29. Radioiodine labeled metaiodobenzylguanidine for imaging and treatment of the adrenal medulla and extra-adrenal paraganglia tumors.- 30. A (188)Re-juvenatiNG JOURNEY WITH HERCULES .- 31. CXCR4 Theranostic Experience from India.- 32. Can VPAC Targeted Cu-67-TP3805 Play a Theranostic Role for Prostate Cancer?: A Quest.- 33. REAL-WORLD EVIDENCE: CLINICAL OUTCOMES IN PRECISION RADIONUCLIDE ONCOLOGY. The WARMTH NIGHTCAP Study of 177Lu-PSMA in Metastatic Prostate Cancer..- 34. Uptake of 68Ga-DOTATATE and 68Ga-DOTATOC in primary neuroendocrine tumors, metastases, and normal liver tissue - isthere a significant difference?.- 35. Theranostics with somatostatin receptor antagonists..- 36. Molecular in-vitro & in-vivo diagnostics as the impartible basis of multimodal therapy approaches in precision oncology .- 37. Molecular imaging platform and radio-pharmaceutical transnational research on Peking University Cancer Hospital.- 38. Dose it possible to targeting HER2 using Affibody receptor radionuclide therapy.